← Leaderboards
Borna Mehrad
University Of Florida
$10,070,955
Attributed
$16,550,480
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$18,161,170 · 9
By mechanism
R01$12,437,915 · 4
U01$2,874,355 · 1
P01$1,610,690 · 1
K08$620,153 · 1
R21$618,057 · 2
Top collaborators
- Reinhard Laubenbacher14 shared
- William J Schroeder5 shared
- C. Edward Rose4 shared
- Robert M Strieter1 shared
Most similar at University Of Florida
Same institution · by research overlap
- Luis Alfonso Sordo Vieira$233,688
- Jingchuan Guo$1,978,842
- Hui Shao$4,879,138
- Natalia Valadares De Moraes$612,000
- Joe G. N. Garcia$45,532,409
Others in their field
Top investigators on “Aspergillosis”
- Robert Andrew Cramer · Sloan-Kettering Inst Can Research$13,470,091
- Tobias M Hohl · Sloan-Kettering Inst Can Research$11,683,839
- Maurizio Del Poeta · Northport Va Medical Center$11,286,990
- Kieren A. Marr · Fred Hutchinson Cancer Research Center$10,461,474
- William J Steinbach · Duke University$8,844,552
- Jarrod R. Fortwendel · University Of South Alabama$6,753,744
Research focus
AspergillosisLungCellsNeutrophilImmune ResponseInfectionImmunityResponseChemokineIn VivoAnimal ModelAspergillusHost DefenseTissuesComplexCessation Of LifeMouse ModelMycosesImmunocompromised HostLeadIn VitroLifeReproduction SporesAntimicrobial
Grant awards (40)
Mechanistic modeling of the innate immune responses of the human lung to understand the inter-individual heterogeneity of COVID-19 pneumonia$733,796
R01 · FY2025 · HL · contact PI
Multiscale modeling of the role of heme during invasive pulmonary aspergillosis$725,912
R01 · FY2025 · AI · contact PI
Mechanistic modeling of the innate immune responses of the human lung to understand the inter-individual heterogeneity of COVID-19 pneumonia$731,876
R01 · FY2024 · HL · contact PI
Assessing the Pulmonary Toxicity of Microplastic Fibers Complexed with Azo Dyes$183,557
R21 · FY2024 · ES · contact PI
Mechanistic modeling of the innate immune responses of the human lung to understand the inter-individual heterogeneity of COVID-19 pneumonia$762,062
R01 · FY2023 · HL · contact PI
Multiscale modeling of the battle over iron in invasive lung infection$739,948
R01 · FY2022 · AI
Multiscale modeling of the battle over iron in invasive lung infection$748,326
R01 · FY2021 · AI
Modular design of multiscale models, with an application to the innate immune response to fungal respiratory pathogens$800,977
U01 · FY2020 · EB
Multiscale modeling of the battle over iron in invasive lung infection$752,823
R01 · FY2020 · AI
Multiscale modeling of the battle over iron in invasive lung infection$600,167
R01 · FY2019 · AI
Modular design of multiscale models, with an application to the innate immune response to fungal respiratory pathogens.$514,632
U01 · FY2019 · EB
Modular design of multiscale models, with an application to the innate immune response to fungal respiratory pathogens$223,843
U01 · FY2019 · EB
Multiscale modeling of the battle over iron in invasive lung infection$619,827
R01 · FY2018 · AI
Modular design of multiscale models, with an application to the innate immune response to fungal respiratory pathogens.$604,681
U01 · FY2018 · EB
Modular design of multiscale models, with an application to the innate immune response to fungal respiratory pathogens.$730,222
U01 · FY2017 · EB
Neutrophils and adaptive immunity against invasive aspergillosis$237,000
R21 · FY2016 · AI · contact PI
Fibrocytes in human pulmonary fibrosis$541,653
R01 · FY2015 · HL · contact PI
Neutrophils and adaptive immunity against invasive aspergillosis$197,500
R21 · FY2015 · AI · contact PI
Fibrocytes in human pulmonary fibrosis$537,042
R01 · FY2014 · HL · contact PI
Fibrocytes in human pulmonary fibrosis$519,856
R01 · FY2013 · HL · contact PI
NK cells in host defense against invasive aspergillosis$321,268
R01 · FY2013 · HL · contact PI
Fibrocytes in human pulmonary fibrosis$544,187
R01 · FY2012 · HL · contact PI
NK cells in host defense against invasive aspergillosis$337,466
R01 · FY2012 · HL · contact PI
Fibrocytes in human pulmonary fibrosis$569,102
R01 · FY2011 · HL · contact PI
NK cells in host defense against invasive aspergillosis$340,875
R01 · FY2011 · HL · contact PI
NK cells in host defense against invasive aspergillosis$340,875
R01 · FY2010 · HL · contact PI
NK cells in host defense against invasive aspergillosis$340,875
R01 · FY2009 · HL · contact PI
ROLE OF INFLAMMATION IN PULMONARY INJURY$1,610,690
P01 · FY2008 · HL · contact PI
NK cells in host defense against invasive aspergillosis$287,299
R01 · FY2007 · HL · contact PI
NK cells in host defense against invasive aspergillosis$295,880
R01 · FY2006 · HL · contact PI
NK cells in host defense against invasive aspergillosis$358,800
R01 · FY2005 · HL
NK cells in host defense against invasive aspergillosis$312,000
R01 · FY2004 · HL
THE ROLE OF CXC CHEMOKINES IN INVASIVE ASPERGILLOSIS$123,390
K08 · FY2004 · HL
NK cells in host defense against invasive aspergillosis$39,000
R01 · FY2004 · HL
NK cells in host defense against invasive aspergillosis$337,000
R01 · FY2003 · HL
THE ROLE OF CXC CHEMOKINES IN INVASIVE ASPERGILLOSIS$123,390
K08 · FY2003 · HL
THE ROLE OF CXC CHEMOKINES IN INVASIVE ASPERGILLOSIS$123,390
K08 · FY2002 · HL
THE ROLE OF CXC CHEMOKINES IN INVASIVE ASPERGILLOSIS$123,390
K08 · FY2001 · HL
THE ROLE OF CXC CHEMOKINES IN INVASIVE ASPERGILLOSIS$83,228
K08 · FY2000 · HL
THE ROLE OF CXC CHEMOKINES IN INVASIVE ASPERGILLOSIS$43,365
K08 · FY2000 · HL